---
type: Session
title: "Variant summary report added, requested after comparing against a lab's own workflow"
description: "Session log of 2026-09-22."
tags: [session]
session_date: 2026-09-22
session_label: "2026-09-22"
generated: { by: claude-code/agent }
moved_from: docs/PROGRESS.md (verbatim, 2026-10-04)
---

# 2026-09-22: Variant summary report added, requested after comparing against a lab's own workflow

The user shared their own pre-existing Excel/VBA workbook (a manual primer/probe conservation
workflow for a *Blastocystis* qPCR assay: BLAST web UI → SAM export → BioEdit alignment →
column-masking → a hand-built "primer/probe report" tab lumping identical sequence variants with
a count and percentage) and asked for a detailed comparison against this project. That comparison
surfaced one real capability gap worth acting on immediately: the workbook's own
`PRIMER_PROBE_RAPPORT` tab -- exactly the kind of report the user built this project to replace --
had no equivalent here, and the user asked for it back, generalised from per-region to the whole
fragment (lump identical forward+probe+reverse combinations, not just one oligo at a time).

Implemented as `specificity/variants.py` (`build_variant_summary`), wired into `pipeline.py`
whenever `specificity` is supplied, with no new required section or verdict -- it is purely a
different view of evidence the specificity assessment already scored (`SiteResult.q_aln`/`s_aln`
carries the exact alignment string needed; grouping by `(q_aln, s_aln)` lumps identical variants
without needing any new NCBI call), the same design already used for `taxonomy/rollup.py`'s
species/genus/family aggregation. Two variant tables: per-oligo (forward/probe/reverse, from the
target tier's own sites) and per-fragment (the target tier's own predicted amplicons, keyed by the
combined forward+probe+reverse variant, only when all three sites were fully re-aligned -- not a
`blast_partial_worst_case` estimate). New report.html section (reuses the existing `aln_html`
Jinja filter for the alignment display, so it looks like the rest of the report rather than the
workbook's plain dot-diff notation) and two new xlsx sheets ("Oligo variants", "Fragment
variants"). 10 new unit tests (`tests/test_variants.py`, in the style of `tests/test_pairing.py`'s
directly-constructed `SiteResult`/`AmpliconResult` fixtures) plus a manual end-to-end smoke check
(constructed a `SpecificityResult` with real target-tier sites/amplicons, rendered both
`report.html` and `results.xlsx`, inspected the actual output) since none of the existing
`render_report` tests exercised target-tier data and so would not have caught a template error in
the new section. 321 tests total (up from 311), `ruff check`/`ruff format --check` both clean.

Not yet done: this is a code-only session (no NCBI access here) -- the new section has not been
seen on a real live run. Also not yet decided: whether/when to tag this as a point release: SPEC.md
scopes the roadmap through v1.0.0 (already tagged) and this is an addition the user asked for
directly in conversation, not one of the originally planned phases -- left for the user to decide
when to version and tag it, per CLAUDE.md's git-tagging convention (annotated tags per phase).
